SCHEMBL9499474

SCHEMBL9499474

CC(C)(NC(N)=O)C(=O)NCCCO[N+](=O)[O-]

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
EPHX1 P07099 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
POLB P06746 1/20 0.33
GLA P06280 1/20 0.32
HPGD P15428 1/20 0.32
ALOX12 P18054 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA4 P22748 2/20 0.32
CA9 Q16790 2/20 0.32
BCHE P06276 2/20 0.31
ACHE P22303 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9498550 0.91 MEN1 (0.37) MEN1KMT2AKDM4EMAPTCYP2C9
SCHEMBL9498097 0.86 MEN1 (0.35) MEN1KMT2AEPHX1KDM4EMAPT
SCHEMBL9500067 0.83 KDM4C (0.49) MEN1KMT2AEPHX1KDM4EMAPT
SCHEMBL9501618 0.82 KDM4E (0.37) MEN1KMT2AEPHX1KDM4EMAPT
SCHEMBL9499926 0.80 CA12 (0.38) MEN1KMT2AALDH1A1SMN1; SMN2CA12
SCHEMBL9499270 0.78 MEN1 (0.36) MEN1KMT2AKDM4EMAPTCYP2C9
SCHEMBL20381102 0.76 NPC1 (0.40) MEN1KMT2AEPHX1MAPTALDH1A1
Fumaric Acid SCHEMBL9795259 0.75 PDE5A (0.37) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL9500139 0.75 EPHX1 (0.38) MEN1KMT2AEPHX1KDM4EMAPT
SCHEMBL9795257 0.74 EPHX1 (0.33) EPHX1KDM4EMAPTCA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0367019-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING NITROXYALKYL AMINE WITH AN AMIDE FUNCTION, AND METHOD FOR THE PREPARATION OF THE COMPOUNDS Roche Diagnostics GmbH (DE) 1993-05-12 EP disclosed
US-5037849-A For treatment of heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1991-08-06 US disclosed